As of November 2024, Beximco Pharmaceuticals has a market cap of $126.61M. This makes Beximco Pharmaceuticals the world's 19952th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $238.20M | -2.53% |
2023 | $244.38M | -23.15% |
2022 | $317.99M | -55.56% |
2021 | $715.48M | 21.50% |
2020 | $588.87M | 139.13% |
2019 | $246.26M | 2.22% |
2018 | $240.90M | -25.00% |
2017 | $321.20M | 7.14% |
2016 | $299.79M | 121.89% |
2015 | $135.11M | 51.22% |
2014 | $89.34M | 40.51% |
2013 | $63.59M | -22.67% |
2012 | $82.22M | - |